Preparation and Pharmacokinetics in Rats of Celecoxib Nanosuspension
- VernacularTitle:塞来昔布纳米混悬剂的制备及大鼠体内药动学研究
- Author:
Qiuyan LI
;
Min WANG
;
Peng XIE
;
Juntao LI
;
Qiang XUE
- Publication Type:Journal Article
- Keywords:
Celecoxib;
Nanosuspensions;
Anti-solvent precipitation and high pressure homogenization method;
Pharmacokinetics
- From:
China Pharmacist
2016;19(2):258-261
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To prepare celecoxib nanosuspension ( CXB-NSs) and study the pharmacokinetics of CXB-NSs in rats. Methods:CXB-NSs were prepared by an anti-solvent precipitation and high pressure homogenization method. The particle size, polydispersion index ( PdI) and zeta potential of the nanosuspension were studied. Totally 12 Wistar rats were randomly divided into CXB-NSs group and CXB suspension group, and gastric drug dose was 100 mg·kg-1 . CXB concentration in plasma was determined by HPLC and the pharmacokinetic parameters were calculated by 3P97 software. Results: The particle size, polydispersion index, zeta potential of CXB-NSs was (442. 5 ± 61. 9) nm, 0. 312 ± 0. 057 and ( -31. 6 ± 3. 9) mV, respectively. AUC (0-t) of CXB suspension and CXB-NSs was (5.13 ±0.77) and (13.51 ±3.18) mg·L-1·h, half time (t1/2) was (12.31 ±1.91) and (12.73 ±1.83) h, Tmax was (2. 48 ± 0. 37) and (1. 41 ± 0. 27) h and Cmax was (0. 94 ± 0. 31) and (2. 38 ± 0. 25) mg·L-1 , respectively. Conclusion:CXB-NSs can remarkably increase bioavailability in rats.
